Cancer diagnoses in England hit record high of more than 1,000 people a day

by | Nov 5, 2026 | Health

Cancer diagnoses in England hit record high of more than 1,000 people a day

England’s National Health Service recorded more than 373,000 cancer diagnoses in 2024, marking the highest figure on record, according to the latest cancer registration statistics. This represents an average of 1,021 people diagnosed each day, an increase from 972 daily diagnoses in 2023. The four most common cancer types—prostate, breast, lung, and bowel—accounted for approximately half of all new diagnoses during the period.

The data showed some positive developments in early detection, with 56.7% of first new cancers diagnosed at stage 1 or 2 in 2024, compared to 55.8% in 2023. NHS leadership characterized the trend as evidence of progress, noting that teams across the country are expanding access to testing and screening services closer to communities. However, health officials and cancer organizations urged caution about the figures, emphasizing that diagnostic advances have not been matched by corresponding improvements in treatment timelines.

Current NHS performance falls short of established targets in both diagnosis and treatment phases. In August, 78.6% of patients urgently referred for suspected cancer received either a diagnosis or had cancer ruled out within 28 days, below the 80% target. Treatment initiation rates were even more concerning, with 71.9% of patients beginning cancer treatment within 62 days of urgent referral or consultant upgrade, significantly below the 85% goal.

Experts attributed the rising number of diagnoses partly to an aging population but also highlighted preventable risk factors. Obesity was identified as a major and often underrecognized contributor to cancer incidence. Experts also noted that disparities persist based on geography and socioeconomic status, affecting both cancer likelihood and survival outcomes. Industry representatives called for increased government support, specialist staff, and equipment to improve early detection programs and meet waiting time targets. Screening expansion, particularly for lung cancer, was identified as a key priority for reducing late-stage diagnoses.

Article Attribution | Read More at Article Source

Article summary produced by Claude AI